News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Myelodysplastic Syndrome
April 5, 2020
Treatment of Myelodysplastic Syndrome
Charles H. Weaver, MD
January 24, 2020
Understanding Allogeneic Stem Cell Transplant
Charles H. Weaver, MD
July 30, 2019
Guadecitabine Treatment for Myelodysplastic Syndromes
Charles H. Weaver, MD
February 13, 2019
The CancerConnect Myelodysplastic Syndrome Newsletter
Charles H. Weaver, MD
September 21, 2018
Understanding and Monitoring Your Blood Counts
Charles H. Weaver, MD
August 2, 2018
Revlimid® Reduces Need for Blood Transfusions in Some Myelodysplastic Syndromes
Charles H. Weaver, MD
July 26, 2018
Novel Agent may Reverse Resistance to Targeted Therapy in Acute Leukemia and MDS
Charles H. Weaver, MD
July 20, 2018
Vidaza® Improves Survival in Higher-risk Myelodysplastic Syndromes
Charles H. Weaver, MD
June 30, 2018
Vidaza® Approved for High-risk MDS
Charles H. Weaver, MD
June 20, 2018
Vidaza Improves Survival in High-risk Myelodysplastic Syndrome
Charles H. Weaver, MD
June 20, 2018
Mylotarg® and Vidaza® Effective for Elderly Patients with AML or MDS
Charles H. Weaver, MD
June 9, 2018
Revlimid® Shows Promise in Treatment of Myelofibrosis with Myeloid Metaplasia
Charles H. Weaver, MD
Previous Page
1
2
3
4
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
